Erica Bello

Mamma and Head of target discovery group @TheMilnerInst. Interested in functional genomics, CRISPR technology, photography, travelling and cooking. 🇮🇹 🇪🇺

[Erica Bello @EricaBello4]

Excited to see this work from my Postdoc in Andrew Bassett's lab at @sangerinstitute finally out in the world! https://t.co/Al2v96iCV6 we found an AD-associated variant in PTK2B that actually has a causal effect on chromatin accessibility, gene expression and microglial function

[Erica Bello @EricaBello4]

@SerenaNikZainal @NatureGenet @GeneChChKoh congratulations! @GeneChChKoh

[Milner Therapeutics Institute @TheMilnerInst]

📣 We are looking for a Research Assistant to join our Target Discovery Team, led by @EricaBello4! The role holder will provide experimental support to the team to help deliver projects aligned with key Milner objectives.

Closing 9 February: https://t.co/8HqwUU2z6F

[Erica Bello @EricaBello4]

I am hiring a Research Assistant in my team at the @TheMilnerInst ! This is a great opportunity to apply CRISPR technologies to complex human in-vitro models of disease to identify novel therapeutic targets. Apply here https://t.co/yLx5jibnAN before 9th Feb!

[Milner Therapeutics Institute @TheMilnerInst]

🚀 Launch: Cambridge NeuroWorks Fellowship Programme!

👉 More tickets have been released for the launch event on 18 December: https://t.co/baM5V7zpbJ

👉 Find out more & apply: https://t.co/WLOATVIjC4

[Erica Bello @EricaBello4]

Very proud PI moment. Great job Tom!!

[Matthias Zilbauer @Zilbauer_M]

Very proud of Tom Dennison for presenting our collaborative work on patient-derived organoids at #ELRIGDD24. Amazing job! 👏 Super excited about future collaborations with @MilnerTherapeutics and @EricaBello4. Onward and upward! 💪 @SCICambridge"

[Matthias Zilbauer @Zilbauer_M]

Very proud of Tom Dennison for presenting our collaborative work on patient-derived organoids at #ELRIGDD24. Amazing job! 👏 Super excited about future collaborations with @MilnerTherapeutics and @EricaBello4. Onward and upward! 💪 @SCICambridge"

[Milner Therapeutics Institute @TheMilnerInst]

⚡Research News ⚡

We’re delighted that work at the Milner Institute in collaboration with Professor Matthias Zilbauer has made a promising step toward identifying more precise and personalised treatments for patients with Crohn’s disease 👀

👉 https://t.co/Z9NM5UOIQp

[Xi Chen @XiChenUoM]

So, seqspec has been published. This is a good opportunity to remind everybody that your count matrix, R object, h5ad etc are NOT your raw data. Raw data are fastq files which are only useful when you know the content of your reads. Then ... 1/7 https://t.co/1aKKeMKCnq

[Milner Therapeutics Institute @TheMilnerInst]

📣 Milner Seminars: Focus on neuroinflammation.

25th April at the Jeffrey Cheah Biomedical Centre, @CamBioCampus.

Don't miss Guy Brown (@CamBiochem) & Yujing Gao (Astex) for fantastic talks and networking.

https://t.co/6OTlKQqSvE

[Matt Coelho @MatthewACoelho]

See below for details – please RT!
postdoc
https://t.co/Rdwd5gynhe
ARA
https://t.co/dI6HnDRPil
ARA
https://t.co/NGkvPfrStS

[Britt Adamson @bsadamson]

We tried PE4 out for mouse modeling. Check it out.

[Erica Bello @EricaBello4]

Great opportunity is a fantastic lab! Apply!

[Rawlins Lab @LabRawlins]

Come and join us! We are recruiting a Research Assistant to work on a highly collaborative lung disease project using human organoids and CRISPR. Closing date 5th Feb. @GurdonInstitute with friendly colleagues in Leicester/Nottingham.
https://t.co/simKVj2s5X

[Erica Bello @EricaBello4]

A great opportunity to lead the team that will run the new arrayed CRISPR screening lab at the @TheMilnerInst in collaboration with @AstraZeneca. A great place to work at the interface between academia and industry in a stimulating environment. Highly recommended, apply!

[Milner Therapeutics Institute @TheMilnerInst]

We recently announced a new partnership with AZ and the MRC that will establish a state-of-the-art functional genomics screening lab at the Milner Institute. We’re now delighted to share this exciting new opportunity to be the MTI Lead for the new lab!

https://t.co/MIevhAtbaO

[Claire Armitstead @carmitstead]

I haven’t posted on X since it was twitter but I’m so angry and upset that I will do anything to explain my atom of experience of this horrible, exclusionary new world. https://t.co/NLZEOvZPmE

[Erica Bello @EricaBello4]

Had a fantastic Christmas dinner with the whole Target Discovery Group @TheMilnerIns! Thank you everyone for all your hard work and have a great end of the year!

[Serena Nik-Zainal @SerenaNikZainal]

PAPER OUT!!!🥳

An unfortunate, incidental finding😬
Chemotherapeutic CX-5461 developed 4 patients with BRCA1/2 mutations
in early-phase clinical trials
is a potent mutagen!
@NatureGenet
led by @GeneChChKoh

Funded by @CR_UK @NIHRresearch @BasserBRCA
1/n
https://t.co/IQjpwlJ8Oo

[Erica Bello @EricaBello4]

Exciting times ahead at the @TheMilnerInst! Looking forward to seeing how this collaboration develops

[Milner Therapeutics Institute @TheMilnerInst]

We are delighted to announce a new partnership with @AstraZeneca and @The_MRC, that will establish a new state-of-the-art functional genomics laboratory at the Milner Therapeutics Institute! 🤩

Read more: https://t.co/Dg84f9Tf8a

#FunctionalGenomics #CRISPR

[Milner Therapeutics Institute @TheMilnerInst]

We are delighted to announce a new partnership with @AstraZeneca and @The_MRC, that will establish a new state-of-the-art functional genomics laboratory at the Milner Therapeutics Institute! 🤩

Read more: https://t.co/Dg84f9Tf8a

#FunctionalGenomics #CRISPR

[Anna Schueth, PhD @SchuethAnna]

Everyone has their own requirements in order to grow.
#FlourishMaastricht #AcademicMentalHealth

[David Kent @scienceadvocacy]

New @NatureMedicine paper from @BostonChildrens @sangerinstitute and @YBRI_UoY on clonal dynamics of HSCs pre- and post-gene therapy.

👍 @AlyssaHCull @doctor_msc 👍

Gracious for both the funding and the network connectively from @gatesfoundation

https://t.co/h5j0H17rSD